A number of investment brokers have recently updated their price targets on shares of Amsurg Corp. (NASDAQ:AMSG). According to the latest broker reports outstanding on Monday 9th of May, 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

05/04/2016 – Amsurg Corp. had its “buy” rating reiterated by analysts at Mizuho. They now have a USD 90 price target on the stock.

02/19/2016 – Amsurg Corp. had its “overweight” rating reiterated by analysts at Piper Jaffray. They now have a USD 86 price target on the stock.

01/06/2016 – Barclays began new coverage on Amsurg Corp. giving the company a “equal-weight” rating. They now have a USD 85 price target on the stock.

12/14/2015 – Amsurg Corp. had its “overweight” rating reiterated by analysts at Stephens. They now have a USD 97 price target on the stock.

12/03/2015 – Amsurg Corp. had its “overweight” rating reiterated by analysts at KeyBanc. They now have a USD 92 price target on the stock.

11/30/2015 – Goldman Sachs began new coverage on Amsurg Corp. giving the company a “buy” rating. They now have a USD 101 price target on the stock.

09/16/2015 – JP Morgan began new coverage on Amsurg Corp. giving the company a “overweight” rating. They now have a USD 94 price target on the stock.

08/06/2015 – Amsurg Corp. had its “buy” rating reiterated by analysts at Cantor Fitzgerald. They now have a USD 95 price target on the stock.

08/06/2015 – Amsurg Corp. had its “buy” rating reiterated by analysts at Jefferies. They now have a USD 94 price target on the stock.

05/11/2015 – Amsurg Corp. was upgraded to “buy” by analysts at Zacks. They now have a USD 74 price target on the stock.

05/06/2015 – Amsurg Corp. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 77 price target on the stock.

03/02/2015 – Amsurg Corp. had its “buy” rating reiterated by analysts at Citigroup. They now have a USD 67 price target on the stock.

06/27/2014 – Amsurg Corp. was upgraded to “buy” by analysts at SunTrust. They now have a USD 54 price target on the stock.

06/27/2014 – Amsurg Corp. was upgraded to “outperform” by analysts at Robert W. Baird. They now have a USD 55 price target on the stock.

05/30/2014 – Amsurg Corp. was upgraded to “strong-buy” by analysts at Raymond James. They now have a USD 60 price target on the stock.

The share price of Amsurg Corp. (NASDAQ:AMSG) was up +1.19% during the last day of trading, with a day high of 77.22. 357563 shares were traded during the last session.

The stock’s 50 day moving average is 76.73 and its 200 day moving average is 75.07. The stock’s market capitalization is 4.11B. Amsurg Corp. has a 52-week low of 54.11 and a 52-week high of 87.42.

View other investors thoughts on Amsurg Corp. with our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.